Results
1 -
8 of
8
(Click
here to explore results)
- DNA Damage, DNA Repair and Disease: Volume 2, Chapter 28 The Role of PARP and the Therapeutic Potential of PARP Inhibitors in Cancer. N. J. Curtin
, 2021
, Volume 2
, Pages 319-360
- DNA Damage, DNA Repair and Disease: Volume 2, Chapter 26 Evolving DNA Repair Targets for Cancer Therapy. M. T. Sadiq, S. Madhusudan
, 2021
, Volume 2
, Pages 254-285
- Computational Tools for Chemical Biology, Chapter 13 The Polypharmacology Gap Between Chemical Biology and Drug Discovery. Albert A. Antolin, Jordi Mestres
, 2018
, Pages 349-370
- Conference on Drug Design and Discovery Technologies, Design and Synthesis of Novel Poly ADP-ribose Polymerase 1 (PARP1) Inhibitors for the Treatment of Solid Tumors. J. Priyancy, D. P. Bhumika
, 2020
, Pages 31-35
- Cytotoxic Payloads for Antibody–Drug Conjugates, CHAPTER 8 Topoisomerase Inhibitors as Antibody–Drug Conjugate (ADC) Payloads. Serengulam V. Govindan, Thomas M. Cardillo, David M. Goldenberg
, 2019
, Pages 166-186
- Catalytic Aerobic Oxidations, CHAPTER 2 Aerobic Oxidation Reactions Using Metal-based Homogeneous Systems. G. Urgoitia, M. T. Herrero, R. SanMartin
, 2020
, Pages 16-49
- DNA Damage, DNA Repair and Disease: Volume 2, Subject Index
, 2021
, Volume 2
, Pages 458-479
- DNA Damage, DNA Repair and Disease: Volume 1, Subject Index
, 2021
, Volume 1
, Pages 379-400